JUNS CIK: 1679628

Jupiter Neurosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−0.48
FY24:
−3.91
FY25:
−5.41
Change from FY21 to FY25
millions USD
FY21:
1.03
FY22:
0.98
FY23:
0.45
FY24:
7.65
FY25:
5.43
millions USD
FY21:
–
FY22:
–
FY23:
−0.04
FY24:
3.74
FY25:
0.02
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−5.41

All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data